Logo image of CRWD

CROWDSTRIKE HOLDINGS INC - A (CRWD) Stock Fundamental Analysis

NASDAQ:CRWD - Nasdaq - US22788C1053 - Common Stock - Currency: USD

333.5  -14.23 (-4.09%)

After market: 332.21 -1.29 (-0.39%)

Fundamental Rating

5

Taking everything into account, CRWD scores 5 out of 10 in our fundamental rating. CRWD was compared to 283 industry peers in the Software industry. CRWD has only an average score on both its financial health and profitability. CRWD is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CRWD had positive earnings in the past year.
CRWD had a positive operating cash flow in the past year.
In the past 5 years CRWD reported 4 times negative net income.
Each year in the past 5 years CRWD had a positive operating cash flow.
CRWD Yearly Net Income VS EBIT VS OCF VS FCFCRWD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

CRWD has a better Return On Assets (1.63%) than 67.14% of its industry peers.
The Return On Equity of CRWD (4.14%) is better than 71.02% of its industry peers.
Industry RankSector Rank
ROA 1.63%
ROE 4.14%
ROIC N/A
ROA(3y)-2.93%
ROA(5y)-4.45%
ROE(3y)-10.51%
ROE(5y)-12.25%
ROIC(3y)N/A
ROIC(5y)N/A
CRWD Yearly ROA, ROE, ROICCRWD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

With a decent Profit Margin value of 3.39%, CRWD is doing good in the industry, outperforming 68.55% of the companies in the same industry.
CRWD has a better Gross Margin (75.24%) than 68.20% of its industry peers.
CRWD's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 3.39%
GM 75.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.68%
GM growth 5Y2.95%
CRWD Yearly Profit, Operating, Gross MarginsCRWD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150 -200

6

2. Health

2.1 Basic Checks

CRWD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CRWD has been increased compared to 1 year ago.
CRWD has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CRWD has an improved debt to assets ratio.
CRWD Yearly Shares OutstandingCRWD Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CRWD Yearly Total Debt VS Total AssetsCRWD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 11.13 indicates that CRWD is not in any danger for bankruptcy at the moment.
The Altman-Z score of CRWD (11.13) is better than 87.99% of its industry peers.
CRWD has a debt to FCF ratio of 0.68. This is a very positive value and a sign of high solvency as it would only need 0.68 years to pay back of all of its debts.
CRWD's Debt to FCF ratio of 0.68 is fine compared to the rest of the industry. CRWD outperforms 74.20% of its industry peers.
A Debt/Equity ratio of 0.24 indicates that CRWD is not too dependend on debt financing.
CRWD has a Debt to Equity ratio of 0.24. This is comparable to the rest of the industry: CRWD outperforms 42.40% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 0.68
Altman-Z 11.13
ROIC/WACCN/A
WACC13.9%
CRWD Yearly LT Debt VS Equity VS FCFCRWD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

CRWD has a Current Ratio of 1.86. This is a normal value and indicates that CRWD is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of CRWD (1.86) is comparable to the rest of the industry.
A Quick Ratio of 1.86 indicates that CRWD should not have too much problems paying its short term obligations.
The Quick ratio of CRWD (1.86) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.86
Quick Ratio 1.86
CRWD Yearly Current Assets VS Current LiabilitesCRWD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

9

3. Growth

3.1 Past

CRWD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 48.08%, which is quite impressive.
The Earnings Per Share has been growing by 127.96% on average over the past years. This is a very strong growth
CRWD shows a strong growth in Revenue. In the last year, the Revenue has grown by 31.35%.
Measured over the past years, CRWD shows a very strong growth in Revenue. The Revenue has been growing by 65.01% on average per year.
EPS 1Y (TTM)48.08%
EPS 3Y127.96%
EPS 5YN/A
EPS Q2Q%13.41%
Revenue 1Y (TTM)31.35%
Revenue growth 3Y51.75%
Revenue growth 5Y65.01%
Sales Q2Q%28.52%

3.2 Future

The Earnings Per Share is expected to grow by 25.55% on average over the next years. This is a very strong growth
CRWD is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 25.29% yearly.
EPS Next Y24.34%
EPS Next 2Y20.6%
EPS Next 3Y22.45%
EPS Next 5Y25.55%
Revenue Next Year28.83%
Revenue Next 2Y25.04%
Revenue Next 3Y23.98%
Revenue Next 5Y25.29%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CRWD Yearly Revenue VS EstimatesCRWD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 5B 10B 15B 20B
CRWD Yearly EPS VS EstimatesCRWD Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 10 15 20 25

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 86.62, which means the current valuation is very expensive for CRWD.
Compared to the rest of the industry, the Price/Earnings ratio of CRWD is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 29.35. CRWD is valued rather expensively when compared to this.
CRWD is valuated quite expensively with a Price/Forward Earnings ratio of 74.45.
CRWD's Price/Forward Earnings ratio is in line with the industry average.
CRWD is valuated expensively when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 86.62
Fwd PE 74.45
CRWD Price Earnings VS Forward Price EarningsCRWD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRWD is on the same level as its industry peers.
CRWD's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 74.67
EV/EBITDA 397.43
CRWD Per share dataCRWD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as CRWD's earnings are expected to grow with 22.45% in the coming years.
PEG (NY)3.56
PEG (5Y)N/A
EPS Next 2Y20.6%
EPS Next 3Y22.45%

0

5. Dividend

5.1 Amount

No dividends for CRWD!.
Industry RankSector Rank
Dividend Yield N/A

CROWDSTRIKE HOLDINGS INC - A

NASDAQ:CRWD (3/7/2025, 8:16:19 PM)

After market: 332.21 -1.29 (-0.39%)

333.5

-14.23 (-4.09%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-26 2024-11-26/amc
Earnings (Next)03-11 2025-03-11/amc
Inst Owners72.36%
Inst Owner Change1.52%
Ins Owners1.5%
Ins Owner Change25.04%
Market Cap82.14B
Analysts80
Price Target410.6 (23.12%)
Short Float %4.07%
Short Ratio2.96
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9%
Min EPS beat(2)5.05%
Max EPS beat(2)12.96%
EPS beat(4)4
Avg EPS beat(4)8.3%
Min EPS beat(4)1.99%
Max EPS beat(4)13.21%
EPS beat(8)8
Avg EPS beat(8)11.18%
EPS beat(12)12
Avg EPS beat(12)18.39%
EPS beat(16)16
Avg EPS beat(16)28.02%
Revenue beat(2)1
Avg Revenue beat(2)-0.3%
Min Revenue beat(2)-1.42%
Max Revenue beat(2)0.82%
Revenue beat(4)1
Avg Revenue beat(4)-0.5%
Min Revenue beat(4)-1.42%
Max Revenue beat(4)0.82%
Revenue beat(8)2
Avg Revenue beat(8)-0.43%
Revenue beat(12)5
Avg Revenue beat(12)0.31%
Revenue beat(16)9
Avg Revenue beat(16)0.89%
PT rev (1m)4.48%
PT rev (3m)8.16%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.73%
EPS NY rev (1m)0%
EPS NY rev (3m)3.39%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.09%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)0.83%
Valuation
Industry RankSector Rank
PE 86.62
Fwd PE 74.45
P/S 21.96
P/FCF 74.67
P/OCF 59.4
P/B 26.86
P/tB 36.89
EV/EBITDA 397.43
EPS(TTM)3.85
EY1.15%
EPS(NY)4.48
Fwd EY1.34%
FCF(TTM)4.47
FCFY1.34%
OCF(TTM)5.61
OCFY1.68%
SpS15.19
BVpS12.41
TBVpS9.04
PEG (NY)3.56
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.63%
ROE 4.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 3.39%
GM 75.24%
FCFM 29.41%
ROA(3y)-2.93%
ROA(5y)-4.45%
ROE(3y)-10.51%
ROE(5y)-12.25%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.68%
GM growth 5Y2.95%
F-Score7
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 0.68
Debt/EBITDA 3.76
Cap/Depr 142.26%
Cap/Sales 7.56%
Interest Coverage N/A
Cash Conversion 699.06%
Profit Quality 868.2%
Current Ratio 1.86
Quick Ratio 1.86
Altman-Z 11.13
F-Score7
WACC13.9%
ROIC/WACCN/A
Cap/Depr(3y)213.86%
Cap/Depr(5y)234.6%
Cap/Sales(3y)9.62%
Cap/Sales(5y)10.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.08%
EPS 3Y127.96%
EPS 5YN/A
EPS Q2Q%13.41%
EPS Next Y24.34%
EPS Next 2Y20.6%
EPS Next 3Y22.45%
EPS Next 5Y25.55%
Revenue 1Y (TTM)31.35%
Revenue growth 3Y51.75%
Revenue growth 5Y65.01%
Sales Q2Q%28.52%
Revenue Next Year28.83%
Revenue Next 2Y25.04%
Revenue Next 3Y23.98%
Revenue Next 5Y25.29%
EBIT growth 1Y98.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year55.38%
EBIT Next 3Y36.66%
EBIT Next 5Y29.54%
FCF growth 1Y85.2%
FCF growth 3Y46.95%
FCF growth 5YN/A
OCF growth 1Y67.15%
OCF growth 3Y48.43%
OCF growth 5YN/A